Company / EPS (Basic)
Voyager Therapeutics, Inc. EPS (Basic) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$3.08
FY2025
5-year range
-$1.89 / $3.08
FY2021-FY2025
Trend
+354.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) changed +355% YoY in FY2025, a notable deviation from the 5-year average annual change of +67%.
Based on SEC 10-K filings.
3.08 in FY2025 with a 3-year CAGR of +46.0%.
Improved from $-1.89 to $3.08 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +46.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 354.5% year-over-year.
- Lowest eps (basic) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.08 | +354.5% |
| FY2024 | -$1.21 | +36.0% |
| FY2023 | -$1.89 | -290.9% |
| FY2022 | $0.99 | +181.8% |
| FY2021 | -$1.21 | +56.0% |
| FY2020 | -$2.75 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026